How Much Bacteriostatic Water for CJC-1295 + Ipamorelin? (Chart)

To reconstitute a standard 5 mg or 10 mg vial of CJC-1295 and Ipamorelin for laboratory research, investigators typically add 1.0 mL to 3.0 mL of bacteriostatic water, depending on the desired target concentration (mg/mL or mcg/μL). For example, diluting a 10 mg combined lyophilized vial with 2.0 mL of bacteriostatic water yields a precise working concentration of 5.0 mg/mL (5.0 mcg/μL).

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

To reconstitute a standard 5 mg or 10 mg vial of CJC-1295 and Ipamorelin for laboratory research, investigators typically add 1.0 mL to 3.0 mL of bacteriostatic water, depending on the desired target concentration (mg/mL or mcg/μL). For example, diluting a 10 mg combined lyophilized vial with 2.0 mL of bacteriostatic water yields a precise working concentration of 5.0 mg/mL (5.0 mcg/μL).

Reviewed by PX1 Research scientific team

Key takeaways

  • Determining how much bacteriostatic water for [CJC-1295](/research-peptides/cjc-1295-no-dac) + [Ipamorelin](/research-peptides/ipamorelin) reconstitutions depends primarily on the total mass contained in the lyophilized vial and the target volumetric concentration required for the assay protocol.
  • Calculating the working concentration of a reconstituted research peptide follows basic stoichiometry and volumetric dilution formulas ($C = m / V$).
  • The following reference chart outlines final stock concentrations across common lyophilized vial sizes (5 mg, 10 mg, and 10 mg 1:1 ratio blends) when combined with standard fill volumes of 0.9% benzyl alcohol preserved diluent.
  • A standard operating procedure (SOP) for reconstituting lyophilized peptides requires strict aseptic technique under a laminar flow hood or clean bench setup.

Reconstitution Fundamentals: Diluent Volume Selection for CJC-1295 / Ipamorelin

Determining how much bacteriostatic water for CJC-1295 + Ipamorelin reconstitutions depends primarily on the total mass contained in the lyophilized vial and the target volumetric concentration required for the assay protocol. Laboratory researchers working with growth hormone secretagogues must establish exact solution concentrations to ensure reproducible pipetting and volumetric accuracy. Reconstituting with 0.9% benzyl alcohol-preserved water (bacteriostatic water) prevents microbial proliferation, enabling repeated sampling from multi-dose research vials over extended experimental timelines.

In vitro and preclinical research protocols often utilize either separate vials of CJC-1295 and Ipamorelin or a pre-formulated ratio blend. For a standard 10 mg total mass vial, such as the CJC-1295 No DAC / Ipamorelin 10mg blend, adding 1.0 mL of diluent creates a concentration of 10 mg/mL, whereas adding 2.0 mL yields 5 mg/mL, and 5.0 mL yields 2 mg/mL. Choosing the appropriate diluent volume balances accurate volumetric delivery with complete peptide solubility and vial headspace constraint limits. Researchers can also utilize our interactive reconstitution calculator to quickly model custom volumetric ratios before handling reagents.

Concentration Mathematics and Diluent Arithmetic

Calculating the working concentration of a reconstituted research peptide follows basic stoichiometry and volumetric dilution formulas ($C = m / V$). Where $C$ represents the final concentration, $m$ represents the total mass of active peptide cake in milligrams, and $V$ represents the volume of added diluent in milliliters. Because lyophilized powder contributes negligible liquid volume upon full dissolution, the final solution volume is effectively equal to the volume of bacteriostatic water added.

For instance, if a researcher possesses a 5 mg vial of CJC-1295 No DAC and reconstitutes it with 2.5 mL of bacteriostatic water, the resulting concentration is calculated as follows: $5.0\text{ mg} / 2.5\text{ mL} = 2.0\text{ mg/mL}$. Expressed in microgram units commonly measured in laboratory micro-titrations, $2.0\text{ mg/mL}$ corresponds to $2,000\text{ mcg/mL}$, or $2.0\text{ mcg}$ per microliter (μL). When evaluating complex multi-peptide matrices, each component's individual concentration must be calculated based on its specific ratio mass within the lyophilized matrix.

CJC-1295 + Ipamorelin Reconstitution Chart (1 mL to 5 mL Diluents)

The following reference chart outlines final stock concentrations across common lyophilized vial sizes (5 mg, 10 mg, and 10 mg 1:1 ratio blends) when combined with standard fill volumes of 0.9% benzyl alcohol preserved diluent. Researchers should select the volume that best aligns with their liquid handling instrumentation and pipetting tolerance ranges.

**Lyophilized Mass vs. Bacteriostatic Water Volume Reference Table:** - **5 mg Total Mass Vial** - 1.0 mL Diluent = 5.0 mg/mL (5.0 mcg/μL) - 2.0 mL Diluent = 2.5 mg/mL (2.5 mcg/μL) - 2.5 mL Diluent = 2.0 mg/mL (2.0 mcg/μL) - 3.0 mL Diluent = 1.67 mg/mL (1.67 mcg/μL) - 5.0 mL Diluent = 1.0 mg/mL (1.0 mcg/μL) - **10 mg Total Mass Vial (or 5mg/5mg Blend)** - 1.0 mL Diluent = 10.0 mg/mL (10.0 mcg/μL) [5 mg/mL per component] - 2.0 mL Diluent = 5.0 mg/mL (5.0 mcg/μL) [2.5 mg/mL per component] - 2.5 mL Diluent = 4.0 mg/mL (4.0 mcg/μL) [2.0 mg/mL per component] - 3.0 mL Diluent = 3.33 mg/mL (3.33 mcg/μL) [1.67 mg/mL per component] - 5.0 mL Diluent = 2.0 mg/mL (2.0 mcg/μL) [1.0 mg/mL per component] When exploring our comprehensive catalog of research peptides, verifying batch mass on the product packaging ensures exact arithmetic execution before entering the laboratory environment.

Step-by-Step Laboratory Reconstitution Protocol

A standard operating procedure (SOP) for reconstituting lyophilized peptides requires strict aseptic technique under a laminar flow hood or clean bench setup. Equipment required includes sterile bacteriostatic water, alcohol prep pads, low-retention micro-syringes or volumetric pipettes, and sterile polypropylene storage microcentrifuge tubes.

1. Remove the protective flip-off cap from the lyophilized CJC-1295 / Ipamorelin vial and sanitize the rubber septum using a 70% isopropyl alcohol swab. Allow it to air dry fully. 2. Draw the target volume of bacteriostatic water using a sterile syringe. 3. Insert the needle through the center of the septum at a slight angle. Direct the fluid stream gently against the glass wall of the vial to minimize shear force and foam formation on the peptide cake. 4. Allow the diluent to passively saturate the cake. Gently swirl the vial in a circular motion on the benchtop—do not shake vigorously, as mechanical agitation can induce protein aggregation or denature delicate peptide chains. 5. Confirm visually that the solution is completely clear, colorless, and free of visible particulate matter before aliquoting or drawing working samples.

Solution Stability, pH Factors, and Antimicrobial Preservation

Lyophilized research peptides remain highly stable at frozen temperatures (-20°C to -80°C) prior to reconstitution. However, once reconstituted in liquid solution, peptide degradation pathways—including hydrolysis, oxidation, and deamidation—accelerate significantly. Bacteriostatic water contains 0.9% (9 mg/mL) benzyl alcohol, which serves as a bacteriostatic preservative to inhibit bacterial proliferation during repeated laboratory sampling.

Reconstituted CJC-1295 and Ipamorelin solutions maintain structural integrity when stored under refrigeration at 2°C to 8°C for up to 28 days. Maintaining a slightly acidic to neutral pH (pH 5.0 to 7.0) helps optimize chemical stability in aqueous media. Exposure to ambient light, elevated temperatures, or repeated freeze-thaw cycles should be strictly avoided to prevent physical denaturation or cleavage of peptide bonds.

Multi-Peptide Blends vs. Individual Lyophilized Vials

In cell culture and animal tissue models, investigators frequently compare the physiological impact of co-administering synergistic secretagogues versus isolated compounds. CJC-1295 functions as a synthetic growth-hormone-releasing hormone (GHRH) analog that binds to GHRH receptors, while Ipamorelin acts as a selective growth hormone secretagogue receptor (GHSR-1a) agonist.

When purchasing pre-mixed formulations, such as a 5mg/5mg combination vial, researchers benefit from uniform molar exposure within a single reconstitution. Alternatively, purchasing individual vials of CJC-1295 No DAC and Ipamorelin allows custom ratio adjustments in complex dose-response assays. When preparing separate vials, each compound is reconstituted independently before combining calculated aliquots in working assay buffers.

Aliquoting Strategies and Single-Use Storage Protocols

To maximize research workflow efficiency and maintain long-term peptide stability, laboratories routinely employ aliquoting strategies. Subjecting a single reconstituted stock vial to repeated thermal cycling or open-air sampling increases contamination risk and accelerates chemical breakdown. Instead, dividing the freshly reconstituted solution into single-use micro-aliquots preserves material quality across multi-week studies.

After complete dissolution in bacteriostatic water, aliquot working volumes into sterile, low-binding polypropylene microcentrifuge tubes (e.g., 100 μL to 200 μL per tube). Store working aliquots intended for immediate use (within 14–28 days) at 2°C to 8°C. For long-term study retention spanning several months, store un-necked aliquots at -20°C or -80°C. Avoid conventional frost-free freezers, as their automated temperature fluctuations induce damaging freeze-thaw stress.

Comparative Secretagogue Analysis: CJC-1295, Ipamorelin, and GHRP-6

Growth hormone secretagogues are generally classified by their receptor binding affinity and downstream signaling kinetics. CJC-1295 is studied as a long-acting growth-hormone-releasing hormone that sustains GH and downstream IGF-1 levels for tissue repair research. In contrast, Ipamorelin is a pentapeptide ghrelin mimetic that selectively stimulates pituitary GH release without significantly elevating cortisol or prolactin levels in preclinical animal models.

Comparing these compounds alongside other classical secretagogues like GHRP-6 provides valuable context for receptor crosstalk studies. While GHRP-6 also targets the GHSR-1a receptor, preclinical data indicate that GHRP-6 triggers broader neuroendocrine activation, including moderate ghrelin-induced appetite signaling and transient increases in ACTH. Combining a GHRH agonist (CJC-1295) with a selective ghrelin receptor agonist (Ipamorelin) produces a amplified, dual-pathway GH release in vitro, which is why combination research models remain widely utilized in biochemical studies.

Quality Assurance: HPLC, MS, and Endotoxin Verification

Reliable experimental data depend entirely on reagent purity and batch consistency. Low-purity peptide preparations containing truncated sequence fragments, synthesis side-products, or residual heavy metals introduce significant confounding variables into cell viability and signaling assays.

At PX1 Research, all research compounds undergo rigorous analytical verification. Every batch is evaluated via High-Performance Liquid Chromatography (HPLC) to confirm mass purity above 99% and Mass Spectrometry (MS) to verify exact molecular weight. Additionally, endotoxin testing confirms limits suitable for sensitive cell culture and in vivo rodent models. Researchers can review batch-specific test results on our dedicated Certificate of Analysis (COA) page before initiating experimental protocols.

Frequently Asked Questions

How much bacteriostatic water should I add to a 10 mg CJC-1295 + Ipamorelin vial?

Adding 2.0 mL of bacteriostatic water to a 10 mg vial yields a working concentration of 5.0 mg/mL (5.0 mcg/μL). Adding 1.0 mL produces 10.0 mg/mL, while 2.5 mL yields 4.0 mg/mL. Choose the volume that matches your assay volume requirements.

Can sterile water be used instead of bacteriostatic water?

Sterile water (without benzyl alcohol) can be used for single-use, immediate assay applications. However, for multi-dose laboratory storage over several days or weeks, bacteriostatic water containing 0.9% benzyl alcohol is required to inhibit bacterial growth.

How should reconstituted CJC-1295 and Ipamorelin be stored in the lab?

Reconstituted liquid solutions should be stored under refrigeration at 2°C to 8°C for short-term use (up to 28 days). For extended storage, divide the reconstituted solution into single-use aliquots and store at -20°C or -80°C.

Does adding more bacteriostatic water change the potency of the peptide?

No. Adding more diluent changes only the volumetric concentration (mg/mL or mcg/μL), not the total mass of peptide present in the vial. The absolute amount of active material remains constant based on the initial lyophilized vial weight.

Where can I verify the purity and batch analysis of PX1 Research peptides?

Every lot manufactured for PX1 Research is HPLC and MS verified for purity and identity. Batch-specific test results, purity profiles, and endotoxin reports are publicly accessible on our Certificate of Analysis (COA) portal.

What is the difference between CJC-1295 With DAC and No DAC?

CJC-1295 With DAC includes a Drug Affinity Complex that extends its half-life significantly in preclinical models via serum albumin binding. CJC-1295 No DAC (also known as Modified GRF 1-29) lacks this complex, resulting in a shorter, more episodic physiological half-life.

How do I calculate volume using the PX1 Reconstitution Calculator?

Navigate to the reconstitution calculator page on our site, input your total vial mass (e.g., 10 mg), enter the amount of added diluent (e.g., 2 mL), and the calculator will automatically output the concentration in mg/mL and mcg/μL.

What shipping standards apply to PX1 Research peptide orders?

PX1 Research ships all orders directly from our USA facilities located in California and Arizona. Orders placed Monday through Friday before our daily cutoff time qualify for same-day dispatch.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.